Dopamine uptake changes associated with cocaine self-administration. 2009

Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

The present study was designed to reveal the relationship between cocaine-induced dopamine uptake changes and patterns of cocaine self-administration observed under a fixed-ratio schedule. Cocaine was intravenously infused into anesthetized rats, according to inter-infusion intervals obtained from self-administering animals, and dopamine uptake changes (apparent K(m)) were assessed in the nucleus accumbens using voltammetry. The data demonstrate that cocaine-induced dopamine transporter (DAT) inhibition accounts for the accumbal dopamine fluctuations, which are associated with the cyclic regularity of cocaine intake observed during self-administration. Specifically, the inter-infusion intervals that are maintained during cocaine self-administration correlate with the maintenance of a rapidly changing level of dopamine uptake inhibition, which appears to be tightly regulated. Furthermore, this maintained level of dopamine uptake inhibition was found to shift upward using intervals from animals that had shown an escalation in the rate of cocaine self-administration. Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased dopamine uptake rate was found suggesting an upregulation of DAT number in response to a history of high cocaine intake. This is the first demonstration of the tight correlation that exists between the level of dopamine uptake inhibition and rates of cocaine self-administration. Moreover, a new mathematical model was created that quantitatively describes the changes in cocaine-induced dopamine uptake and correctly predicts the level of dopamine uptake inhibition. This model permits a computational interpretation of cocaine-induced dopamine uptake changes during cocaine self-administration.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
January 1988, Progress in neuro-psychopharmacology & biological psychiatry,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
April 1994, Neuroreport,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
June 2005, Synapse (New York, N.Y.),
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
July 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
March 2013, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
June 1998, Nature neuroscience,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
September 2015, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
September 1987, Science (New York, N.Y.),
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
October 2012, Experimental and clinical psychopharmacology,
Erik B Oleson, and Sanjay Talluri, and Steven R Childers, and James E Smith, and David C S Roberts, and Keith D Bonin, and Evgeny A Budygin
December 2010, European journal of pharmacology,
Copied contents to your clipboard!